Paul Brian Kuznik
CIK: 0002156537
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HUMA
Humacyte, Inc.
Director
Discretionary Trading P&L
Holdings
About Kuznik Paul Brian
Kuznik Paul Brian (SEC CIK 0002156537) files insider reports with the SEC as Director of Humacyte, Inc. (HUMA).
Signal8 holds 2 ownership filings by Kuznik Paul Brian (1 Form 3, 1 Form 4), filed between Sep 28, 2026 and Oct 7, 2026. Those filings report 1 transaction, the latest on Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kuznik Paul Brian's filings is in DURHAM, NC.
Recent filings by Kuznik Paul Brian
- Oct 6, 2026: Grant or award of HUMA derivative securities (Form 4, code A).
Other insiders filing for Humacyte, Inc. (HUMA)
- COWARD D SCOTT, Director
- Jones Keith Anthony, Director
- Windham-Bannister Susan Richards, Director
- Constantino Michael T., Director
- Wallace Max N., Director
- Niklason Laura E, President, CEO and Director